Tobiasson M, Pandzic T, Illman J, Nilsson L, et al. Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation. J Clin Oncol 2024;42:1378-1390.
PMID: 38232336